EKF Diagnostics has announced that it has acquired Advanced Diagnostic Laboratory (ADL Health), a Texas based PCR-focused testing laboratory.
ADL Health’s CLIA-certified laboratory covers the fields of clinical, forensic and microbiological tests. The business has ISO 15189 Medical Laboratory accreditation giving it recognition in 44 countries and reflecting ADL Health’s commitment to high standards.
Using its expertise in PCR testing, ADL Health also provides COVID-19 testing needs for dozens of Fortune 500 companies and government agencies. For example, it is a pre-travel COVID-19 testing partner for Air Canada and United Airlines. In addition, ADL Health is expanding its range of testing capabilities across a broader suite of healthcare applications. Under EKF’s ownership, further investment is anticipated to support the deployment of additional equipment and personnel in order to service customer demand.
ADL Health delivers a range of rapid and accurate COVID-19 testing services. Considered the gold standard, due to its precision, ADL’s COVID-19 rRT-PCR test has the capability to detect infection in its earliest stages and ensure a quick turnaround time. On receipt of a test at the lab, results are delivered within 24 hours. This is accomplished by adapting the test to a fast, reliable high throughput format which provides results for thousands of samples on a daily basis.
In addition to corporate and group high-volume COVID testing, ADL Health provides a range of testing options including HomeCollect which is a kit-based home testing service delivering results back within 24 hours. ADL also has a rapid response team ready to be deployed to a business or organisation for on-site testing within hours to help prevent loss of business due to a COVID shutdown. The laboratory also offers a drive-through COVID testing service, as well as a COVID pass digital health app for travelers to present standardized, verifiable proof of a negative COVID test.
While the growth of ADL Health has been accelerated by its COVID testing capabilities, its wider testing offering, including current and planned capabilities, both complement and broaden EKF’s existing diagnostics portfolio, which include test kit manufacturing and point-of-care diagnostic instrumentation.
